{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T13:34:55Z","timestamp":1791984895075,"version":"4.4.0"},"reference-count":155,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T00:00:00Z","timestamp":1767916800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Metabolites"],"abstract":"<jats:p>Breast cancer is a significant public health concern, with triple-negative breast cancer (TNBC) being the most aggressive subtype characterized by considerable heterogeneity and the absence of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) expression. Currently, there are no practical alternatives to chemotherapy, which is associated with a poor prognosis. Therefore, developing new treatments for TNBC is an urgent need. Reactive oxygen species (ROS) and redox adaptation play central roles in TNBC biology. Targeting the redox state has emerged as a promising therapeutic approach, as it is vital to the survival of tumors, including TNBC. Although TNBC does not produce high levels of ROS compared to ER- or PR-positive breast cancers, it relies on mitochondria and oxidative phosphorylation (OXPHOS) to sustain ROS production and create an environment conducive to tumor progression. As a result, novel treatments that can modulate redox balance and target organelles essential for redox homeostasis, such as mitochondria, could be promising for TNBC, an area not yet reviewed in the current scientific literature, thus representing a critical gap. This review addresses that gap by synthesizing current evidence on TNBC biology and its connections to redox state and mitochondrial metabolism, with a focus on innovative strategies such as metal-based compounds (e.g., copper, gold), redox nanoparticles that facilitate anticancer drug delivery, mitochondrial-targeted therapies, and immunomodulatory peptides like GK-1. By integrating mechanistic insights into the redox state with emerging therapeutic approaches, I aim to highlight new redox-centered opportunities to improve TNBC treatments. Moreover, this review uniquely integrates mitochondrial metabolism, redox imbalance, and emerging regulated cell-death pathways, including ferroptosis, cuproptosis, and disulfidptosis, within the context of TNBC metabolic heterogeneity, highlighting translational vulnerabilities and subtype-specific therapeutic opportunities.<\/jats:p>","DOI":"10.3390\/metabo16010060","type":"journal-article","created":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T10:35:52Z","timestamp":1767954952000},"page":"60","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Mitochondrial Redox Vulnerabilities in Triple-Negative Breast Cancer: Integrative Perspectives and Emerging Therapeutic Strategies"],"prefix":"10.3390","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0077-5079","authenticated-orcid":false,"given":"Alfredo","family":"Cruz-Gregorio","sequence":"first","affiliation":[{"name":"Departamento de Fisiolog\u00eda, Instituto Nacional de Cardiolog\u00eda Ignacio Ch\u00e1vez, Tlalpan, Mexico City 14080, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,1,9]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"44","DOI":"10.20892\/j.issn.2095-3941.2019.0210","article-title":"Metabolic Reprogramming in Triple-Negative Breast Cancer","volume":"17","author":"Wang","year":"2020","journal-title":"Cancer Biol. Med."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Dong, R., Wang, J., Guan, R., Sun, J., Jin, P., and Shen, J. (2025). Role of Oxidative Stress in the Occurrence, Development, and Treatment of Breast Cancer. Antioxidants, 14.","DOI":"10.3390\/antiox14010104"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1002\/ajmg.10320","article-title":"Cancer Genetics","volume":"111","author":"Knudson","year":"2002","journal-title":"Am. J. Med. Genet."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of Cancer: The next Generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"ref_5","first-page":"229","article-title":"Global Cancer Statistics 2022: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/s41572-019-0111-2","article-title":"Breast Cancer","volume":"5","author":"Harbeck","year":"2019","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2750","DOI":"10.1172\/JCI45014","article-title":"Identification of Human Triple-Negative Breast Cancer Subtypes and Preclinical Models for Selection of Targeted Therapies","volume":"121","author":"Lehmann","year":"2011","journal-title":"J. Clin. Investig."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2638","DOI":"10.1002\/cncr.23930","article-title":"Sites of Distant Recurrence and Clinical Outcomes in Patients with Metastatic Triple-Negative Breast Cancer: High Incidence of Central Nervous System Metastases","volume":"113","author":"Lin","year":"2008","journal-title":"Cancer"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1002\/biof.1784","article-title":"Redox-Sensitive Signaling Pathways in Renal Cell Carcinoma","volume":"48","author":"Solano","year":"2022","journal-title":"Biofactors"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"437","DOI":"10.3390\/oxygen2040030","article-title":"RONS and Oxidative Stress: An Overview of Basic Concepts","volume":"2","year":"2022","journal-title":"Oxygen"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.virusres.2018.01.003","article-title":"Cellular Redox, Cancer and Human Papillomavirus","volume":"246","author":"Lizano","year":"2018","journal-title":"Virus Res."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1042\/bse0470053","article-title":"Mitochondrial Proton and Electron Leaks","volume":"47","author":"Jastroch","year":"2010","journal-title":"Essays Biochem."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1042\/CS20140542","article-title":"NADPH Oxidases and Cancer","volume":"128","author":"Roy","year":"2015","journal-title":"Clin. Sci."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cbi.2005.12.009","article-title":"Free Radicals, Metals and Antioxidants in Oxidative Stress-Induced Cancer","volume":"160","author":"Valko","year":"2006","journal-title":"Chem. Biol. Interact."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ccell.2020.06.001","article-title":"Oxidative Stress in Cancer","volume":"38","author":"Hayes","year":"2020","journal-title":"Cancer Cell"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Karihtala, P., Kauppila, S., Soini, Y., and Jukkola-Vuorinen, A. (2011). Oxidative Stress and Counteracting Mechanisms in Hormone Receptor Positive, Triple-Negative and Basal-like Breast Carcinomas. BMC Cancer, 11.","DOI":"10.1186\/1471-2407-11-262"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/0959-8049(96)00031-7","article-title":"Prognostic and Aetiological Relevance of 8-Hydroxyguanosine in Human Breast Carcinogenesis","volume":"32A","author":"Musarrat","year":"1996","journal-title":"Eur. J. Cancer"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/s10549-010-1023-8","article-title":"Inhibition of Estrogen Signaling Activates the NRF2 Pathway in Breast Cancer","volume":"124","author":"Yao","year":"2010","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1016\/j.bcp.2011.06.007","article-title":"Catalase Overexpression in Mammary Cancer Cells Leads to a Less Aggressive Phenotype and an Altered Response to Chemotherapy","volume":"82","author":"Glorieux","year":"2011","journal-title":"Biochem. Pharmacol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1158\/1078-0432.CCR-14-0432","article-title":"Comprehensive Genomic Analysis Identifies Novel Subtypes and Targets of Triple-Negative Breast Cancer","volume":"21","author":"Burstein","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s40170-017-0168-x","article-title":"Metabolic Profiling of Triple-Negative Breast Cancer Cells Reveals Metabolic Vulnerabilities","volume":"5","author":"Lanning","year":"2017","journal-title":"Cancer Metab."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1146\/annurev-immunol-101819-082015","article-title":"Mitochondrial Metabolism Regulation of T Cell\u2013Mediated Immunity","volume":"39","author":"Steinert","year":"2021","journal-title":"Annu. Rev. Immunol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.cell.2017.04.004","article-title":"Metabolic Instruction of Immunity","volume":"169","author":"Buck","year":"2017","journal-title":"Cell"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cmet.2015.12.006","article-title":"The Emerging Hallmarks of Cancer Metabolism","volume":"23","author":"Pavlova","year":"2016","journal-title":"Cell Metab."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.immuni.2012.10.020","article-title":"Mitochondria Are Required for Antigen-Specific T Cell Activation through Reactive Oxygen Species Signaling","volume":"38","author":"Sena","year":"2013","journal-title":"Immunity"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1038\/s41590-025-02202-x","article-title":"Mitochondrial Respiration Is Necessary for CD8+ T Cell Proliferation and Cell Fate","volume":"26","author":"Steinert","year":"2025","journal-title":"Nat. Immunol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1186\/s12943-025-02375-x","article-title":"Oxidative Stress in Cancer: From Tumor and Microenvironment Remodeling to Therapeutic Frontiers","volume":"24","author":"Liang","year":"2025","journal-title":"Mol. Cancer"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/nri.2016.107","article-title":"Immunogenic Cell Death in Cancer and Infectious Disease","volume":"17","author":"Galluzzi","year":"2017","journal-title":"Nat. Rev. Immunol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/978-3-319-67577-0_5","article-title":"Immunogenic and Non-Immunogenic Cell Death in the Tumor Microenvironment","volume":"1036","author":"Pitt","year":"2017","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/978-3-319-91287-5_27","article-title":"Hypoxia-\/HIF-1\u03b1-Driven Factors of the Tumor Microenvironment Impeding Antitumor Immune Responses and Promoting Malignant Progression","volume":"1072","author":"Vaupel","year":"2018","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Almansour, N.M. (2022). Triple-Negative Breast Cancer: A Brief Review About Epidemiology, Risk Factors, Signaling Pathways, Treatment and Role of Artificial Intelligence. Front. Mol. Biosci., 9.","DOI":"10.3389\/fmolb.2022.836417"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Obidiro, O., Battogtokh, G., and Akala, E.O. (2023). Triple Negative Breast Cancer Treatment Options and Limitations: Future Outlook. Pharmaceutics, 15.","DOI":"10.20944\/preprints202306.0074.v1"},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Holanek, M., Selingerova, I., Bilek, O., Kazda, T., Fabian, P., Foretova, L., Zvarikova, M., Obermannova, R., Kolouskova, I., and Coufal, O. (2021). Neoadjuvant Chemotherapy of Triple-Negative Breast Cancer: Evaluation of Early Clinical Response, Pathological Complete Response Rates, and Addition of Platinum Salts Benefit Based on Real-World Evidence. Cancers, 13.","DOI":"10.3390\/cancers13071586"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s13058-020-01296-5","article-title":"Triple-Negative Breast Cancer Molecular Subtyping and Treatment Progress","volume":"22","author":"Yin","year":"2020","journal-title":"Breast Cancer Res."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1158\/1078-0432.CCR-09-1091","article-title":"Identification of Markers of Taxane Sensitivity Using Proteomic and Genomic Analyses of Breast Tumors from Patients Receiving Neoadjuvant Paclitaxel and Radiation","volume":"16","author":"Bauer","year":"2010","journal-title":"Clin. Cancer Res."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/S1470-2045(10)70018-8","article-title":"Assessment of an RNA Interference Screen-Derived Mitotic and Ceramide Pathway Metagene as a Predictor of Response to Neoadjuvant Paclitaxel for Primary Triple-Negative Breast Cancer: A Retrospective Analysis of Five Clinical Trials","volume":"11","author":"Juul","year":"2010","journal-title":"Lancet Oncol."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"(2005). Early Breast Cancer Trialists\u2019 Collaborative Group (EBCTCG). Effects of Chemotherapy and Hormonal Therapy for Early Breast Cancer on Recurrence and 15-Year Survival: An Overview of the Randomised Trials. Lancet, 365, 1687\u20131717.","DOI":"10.1016\/S0140-6736(05)66544-0"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1073\/pnas.1821022116","article-title":"Ferroptosis as a Target for Protection against Cardiomyopathy","volume":"116","author":"Fang","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s12282-016-0666-7","article-title":"Docetaxel and Cyclophosphamide as Neoadjuvant Chemotherapy in HER2-Negative Primary Breast Cancer","volume":"24","author":"Nakatsukasa","year":"2017","journal-title":"Breast Cancer"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/s41523-024-00643-5","article-title":"Dose Dense Doxorubicin plus Cyclophosphamide in a Modified KEYNOTE522 Regimen for Triple Negative Breast Cancer","volume":"10","author":"Mai","year":"2024","journal-title":"npj Breast Cancer"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s10637-016-0335-x","article-title":"Randomized Phase II Trial of Cyclophosphamide and the Oral Poly (ADP-Ribose) Polymerase Inhibitor Veliparib in Patients with Recurrent, Advanced Triple-Negative Breast Cancer","volume":"34","author":"Kummar","year":"2016","journal-title":"Investig. New Drugs"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"230","DOI":"10.12701\/yujm.2019.00423","article-title":"Impressive Effect of Cisplatin Monotherapy on a Patient with Heavily Pretreated Triple-Negative Breast Cancer with Poor Performance","volume":"37","author":"Baek","year":"2020","journal-title":"Yeungnam Univ. J. Med."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.breast.2022.04.006","article-title":"Moment of Truth-Adding Carboplatin to Neoadjuvant\/Adjuvant Chemotherapy in Triple Negative Breast Cancer Improves Overall Survival: An Individual Participant Data and Trial-Level Meta-Analysis","volume":"64","author":"Pathak","year":"2022","journal-title":"Breast"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"700","DOI":"10.4143\/crt.2023.1138","article-title":"HER2-Low Breast Cancer: Now and in the Future","volume":"56","author":"Kang","year":"2024","journal-title":"Cancer Res. Treat."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Grosse, C., Noack, P., Grosse, A., Schwarz, H.K., Schrenk, P., Frauchiger-Heuer, H., Langer, R., and Varga, Z. (2025). Prognostic Impact of HER2-Low Expression in Triple-Negative Breast Cancer of High-Grade Special Histological Type and No Special Type. PLoS ONE, 20.","DOI":"10.1371\/journal.pone.0325715"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/s41523-025-00817-9","article-title":"Enhancing HER2-Low Breast Cancer Detection with Quantitative Transcriptomics","volume":"11","author":"Misiakou","year":"2025","journal-title":"npj Breast Cancer"},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Shaaban, A.M., Kaur, T., and Provenzano, E. (2025). HER2-Low Breast Cancer\u2014Current Knowledge and Future Directions. Medicina, 61.","DOI":"10.3390\/medicina61040644"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJMoa2203690","article-title":"Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer","volume":"387","author":"Modi","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.cmet.2020.10.012","article-title":"Metabolic-Pathway-Based Subtyping of Triple-Negative Breast Cancer Reveals Potential Therapeutic Targets","volume":"33","author":"Gong","year":"2021","journal-title":"Cell Metab."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"113861","DOI":"10.1016\/j.biopha.2022.113861","article-title":"Targeting Hypoxia-Inducible Factor-1alpha: A New Strategy for Triple-Negative Breast Cancer Therapy","volume":"156","author":"Liu","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"ref_51","first-page":"59","article-title":"Complex Role of HIF in Cancer: The Known, the Unknown, and the Unexpected","volume":"2","author":"Tiburcio","year":"2014","journal-title":"Hypoxia"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"4633","DOI":"10.1038\/sj.onc.1209597","article-title":"Glycolysis Inhibition for Anticancer Treatment","volume":"25","author":"Pelicano","year":"2006","journal-title":"Oncogene"},{"key":"ref_53","first-page":"114","article-title":"GLUT-1 Expression in Breast Cancer","volume":"38","author":"Okcu","year":"2022","journal-title":"Turk. J. Pathol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"157","DOI":"10.2147\/BCTT.S502670","article-title":"Lactate Dehydrogenase-A-Forming LDH5 Promotes Breast Cancer Progression","volume":"17","author":"Fang","year":"2025","journal-title":"Breast Cancer Targets Ther."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.tibs.2014.06.005","article-title":"The Pentose Phosphate Pathway and Cancer","volume":"39","author":"Patra","year":"2014","journal-title":"Trends Biochem. Sci."},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Yee, L.D., Mortimer, J.E., Natarajan, R., Dietze, E.C., and Seewaldt, V.L. (2020). Metabolic Health, Insulin, and Breast Cancer: Why Oncologists Should Care About Insulin. Front. Endocrinol., 11.","DOI":"10.3389\/fendo.2020.00058"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"5572","DOI":"10.1158\/0008-5472.CAN-20-3242","article-title":"Oxidative Phosphorylation Is a Metabolic Vulnerability in Chemotherapy-Resistant Triple-Negative Breast Cancer","volume":"81","author":"Evans","year":"2021","journal-title":"Cancer Res."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"100949","DOI":"10.1016\/j.neo.2023.100949","article-title":"Mitochondrial Adaptation Decreases Drug Sensitivity of Persistent Triple Negative Breast Cancer Cells Surviving Combinatory and Sequential Chemotherapy","volume":"46","author":"Winter","year":"2023","journal-title":"Neoplasia"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"3909","DOI":"10.1073\/pnas.1816391116","article-title":"Elucidating Cancer Metabolic Plasticity by Coupling Gene Regulation with Metabolic Pathways","volume":"116","author":"Jia","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrclinonc.2016.60","article-title":"Cancer Metabolism: A Therapeutic Perspective","volume":"14","author":"Pestell","year":"2017","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1158\/1078-0432.CCR-17-3070","article-title":"Oxidative Phosphorylation as an Emerging Target in Cancer Therapy","volume":"24","author":"Ashton","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1038\/nature13611","article-title":"Oncogene Ablation-Resistant Pancreatic Cancer Cells Depend on Mitochondrial Function","volume":"514","author":"Viale","year":"2014","journal-title":"Nature"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.bbadis.2016.11.005","article-title":"Nrf2 Signaling Pathway: Pivotal Roles in Inflammation","volume":"1863","author":"Ahmed","year":"2017","journal-title":"Biochim. Biophys. Acta (BBA)-Mol. Basis Dis."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1002\/cam4.2101","article-title":"Nrf2 in Cancers: A Double-edged Sword","volume":"8","author":"Wu","year":"2019","journal-title":"Cancer Med."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.freeradbiomed.2015.06.006","article-title":"Molecular Basis of the Keap1-Nrf2 System","volume":"88","author":"Suzuki","year":"2015","journal-title":"Free Radic. Biol. Med."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"8463","DOI":"10.1074\/jbc.M109.051714","article-title":"Activation of NRF2 by Nitrosative Agents and H2O2 Involves KEAP1 Disulfide Formation*","volume":"285","author":"Fourquet","year":"2010","journal-title":"J. Biol. Chem."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1365-2443.2010.01473.x","article-title":"Molecular Mechanisms of the Keap1\u2013Nrf2 Pathway in Stress Response and Cancer Evolution","volume":"16","author":"Taguchi","year":"2011","journal-title":"Genes Cells"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.freeradbiomed.2015.06.013","article-title":"Epigenetic Regulation of Keap1-Nrf2 Signaling","volume":"88","author":"Guo","year":"2015","journal-title":"Free Radic. Biol. Med."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/ncb2021","article-title":"The Selective Autophagy Substrate P62 Activates the Stress Responsive Transcription Factor Nrf2 through Inactivation of Keap1","volume":"12","author":"Komatsu","year":"2010","journal-title":"Nat. Cell Biol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.molcel.2009.04.029","article-title":"Direct Interaction between Nrf2 and P21(Cip1\/WAF1) Upregulates the Nrf2-Mediated Antioxidant Response","volume":"34","author":"Chen","year":"2009","journal-title":"Mol. Cell"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"42769","DOI":"10.1074\/jbc.M206911200","article-title":"Phosphorylation of Nrf2 at Ser-40 by Protein Kinase C Regulates Antioxidant Response Element-Mediated Transcription*","volume":"277","author":"Huang","year":"2002","journal-title":"J. Biol. Chem."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1073\/pnas.0308347100","article-title":"Scaffolding of Keap1 to the Actin Cytoskeleton Controls the Function of Nrf2 as Key Regulator of Cytoprotective Phase 2 Genes","volume":"101","author":"Kang","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"e2308","DOI":"10.1002\/rmv.2308","article-title":"Nuclear Factor Erythroid 2-Related Factor 2 in Human Papillomavirus-Related Cancers","volume":"32","year":"2022","journal-title":"Rev. Med. Virol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1093\/carcin\/bgn095","article-title":"Nrf2 Enhances Resistance of Cancer Cells to Chemotherapeutic Drugs, the Dark Side of Nrf2","volume":"29","author":"Wang","year":"2008","journal-title":"Carcinogenesis"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"8592348","DOI":"10.1155\/2019\/8592348","article-title":"Potential Applications of NRF2 Inhibitors in Cancer Therapy","volume":"2019","author":"Panieri","year":"2019","journal-title":"Oxid. Med. Cell Longev."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s13277-015-4370-6","article-title":"Estrogen Potentiates Reactive Oxygen Species (ROS) Tolerance to Initiate Carcinogenesis and Promote Cancer Malignant Transformation","volume":"37","author":"Tian","year":"2016","journal-title":"Tumour Biol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"eaba4200","DOI":"10.1126\/scisignal.aba4200","article-title":"Sporadic Activation of an Oxidative Stress\u2013Dependent NRF2-P53 Signaling Network in Breast Epithelial Spheroids and Premalignancies","volume":"13","author":"Pereira","year":"2020","journal-title":"Sci. Signal."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1089\/ars.2019.7962","article-title":"Mitochondrial Superoxide Dismutase: What the Established, the Intriguing, and the Novel Reveal About a Key Cellular Redox Switch","volume":"32","author":"Palma","year":"2020","journal-title":"Antioxid. Redox Signal"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"16916","DOI":"10.1074\/jbc.M410690200","article-title":"Mitochondrial H2O2 Regulates the Angiogenic Phenotype via PTEN Oxidation","volume":"280","author":"Connor","year":"2005","journal-title":"J. Biol. Chem."},{"key":"ref_80","first-page":"84","article-title":"Expresi\u00f3n g\u00e9nica de Mn-super\u00f3xido dismutasa (Mn-SOD) en tejidos con c\u00e1ncer de pr\u00f3stata e hiperplasia prost\u00e1tica benigna","volume":"70","year":"2010","journal-title":"Rev. Mex. Urol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.freeradbiomed.2015.04.001","article-title":"Manganese Superoxide Dismutase (SOD2\/MnSOD)\/Catalase and SOD2\/GPx1 Ratios as Biomarkers for Tumor Progression and Metastasis in Prostate, Colon, and Lung Cancer","volume":"85","author":"Miar","year":"2015","journal-title":"Free Radic. Biol. Med."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/s41419-021-04486-x","article-title":"Targeting Prooxidant MnSOD Effect Inhibits Triple-Negative Breast Cancer (TNBC) Progression and M2 Macrophage Functions under the Oncogenic Stress","volume":"13","author":"Tseng","year":"2022","journal-title":"Cell Death Dis."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1089\/ars.2007.1672","article-title":"NAD+\/NADH and NADP+\/NADPH in Cellular Functions and Cell Death: Regulation and Biological Consequences","volume":"10","author":"Ying","year":"2008","journal-title":"Antioxid. Redox Signal"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/s41392-020-00326-0","article-title":"NADPH Homeostasis in Cancer: Functions, Mechanisms and Therapeutic Implications","volume":"5","author":"Ju","year":"2020","journal-title":"Sig Transduct. Target. Ther."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.ccell.2014.11.019","article-title":"Glutathione and Thioredoxin Antioxidant Pathways Synergize to Drive Cancer Initiation and Progression","volume":"27","author":"Harris","year":"2015","journal-title":"Cancer Cell"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1146\/annurev-pathmechdis-012419-032711","article-title":"Mitochondrial Dynamics and Its Involvement in Disease","volume":"15","author":"Chan","year":"2020","journal-title":"Annu. Rev. Pathol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"4814","DOI":"10.1038\/onc.2012.494","article-title":"Mitochondrial Dynamics Regulates Migration and Invasion of Breast Cancer Cells","volume":"32","author":"Zhao","year":"2013","journal-title":"Oncogene"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"4037","DOI":"10.1111\/cas.15568","article-title":"The Emerging Multifaceted Role of PINK1 in Cancer Biology","volume":"113","author":"Wang","year":"2022","journal-title":"Cancer Sci."},{"key":"ref_89","first-page":"39","article-title":"Mitochondrial Dynamics in Breast Cancer Metastasis: From Metabolic Drivers to Therapeutic Targets","volume":"3","author":"Ruidas","year":"2025","journal-title":"Oncol. Adv."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"e6987","DOI":"10.1002\/cam4.6987","article-title":"Mitochondrial Dynamics as a Novel Treatment Strategy for Triple-negative Breast Cancer","volume":"13","author":"Wang","year":"2024","journal-title":"Cancer Med."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1007\/s13346-021-00996-5","article-title":"Nanodiamonds and Their Potential Applications in Breast Cancer Therapy: A Narrative Review","volume":"12","author":"Tjo","year":"2022","journal-title":"Drug Deliv. Transl. Res."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"e9130020","DOI":"10.26599\/NTM.2023.9130020","article-title":"On Nano-Solutions to Overcome Cancer Hypoxia and Resistance","volume":"2","author":"Chen","year":"2023","journal-title":"Nano TransMed"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"9130001","DOI":"10.26599\/NTM.2022.9130001","article-title":"Evoking Pyroptosis with Nanomaterials for Cancer Immunotherapy: Current Boom and Novel Outlook","volume":"1","author":"Wang","year":"2022","journal-title":"Nano TransMed"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1158\/1535-7163.MCT-17-0407","article-title":"Metabolite Profiling Reveals the Glutathione Biosynthetic Pathway as a Therapeutic Target in Triple-Negative Breast Cancer","volume":"17","author":"Beatty","year":"2018","journal-title":"Mol. Cancer Ther."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","article-title":"Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death","volume":"149","author":"Dixon","year":"2012","journal-title":"Cell"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.cell.2013.12.010","article-title":"Regulation of Ferroptotic Cancer Cell Death by GPX4","volume":"156","author":"Yang","year":"2014","journal-title":"Cell"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"111008","DOI":"10.1016\/j.cellsig.2023.111008","article-title":"NOX4 Alleviates Breast Cancer Cell Aggressiveness by Co-Ordinating Mitochondrial Turnover through PGC1\u03b1\/Drp1 Axis","volume":"115","author":"Bhadane","year":"2024","journal-title":"Cell. Signal."},{"key":"ref_98","doi-asserted-by":"crossref","unstructured":"Xiong, Y., Weng, Y., Zhu, S., Qin, J., Feng, J., Jing, X., Luo, C., Gong, W., Sun, R., and Peng, M. (2025). NOX4 Modulates Breast Cancer Progression through Cancer Cell Metabolic Reprogramming and CD8+ T Cell Antitumor Activity. Front. Immunol., 16.","DOI":"10.3389\/fimmu.2025.1534936"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1038\/s42003-021-02805-8","article-title":"DLST-Dependence Dictates Metabolic Heterogeneity in TCA-Cycle Usage among Triple-Negative Breast Cancer","volume":"4","author":"Shen","year":"2021","journal-title":"Commun. Biol."},{"key":"ref_100","doi-asserted-by":"crossref","unstructured":"Capeloa, T., Krzystyniak, J., Rodriguez, A.C., Payen, V.L., Zampieri, L.X., Pranzini, E., Derouane, F., Vazeille, T., Bouzin, C., and Duhoux, F.P. (2022). MitoQ Prevents Human Breast Cancer Recurrence and Lung Metastasis in Mice. Cancers, 14.","DOI":"10.3390\/cancers14061488"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ejpb.2023.10.014","article-title":"Diselenium-Linked Dimeric Prodrug Nanomedicine Breaking the Intracellular Redox Balance for Triple-Negative Breast Cancer Targeted Therapy","volume":"193","author":"Chen","year":"2023","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"ref_102","doi-asserted-by":"crossref","unstructured":"Curcio, M., Brindisi, M., Cirillo, G., Frattaruolo, L., Leggio, A., Rago, V., Nicoletta, F.P., Cappello, A.R., and Iemma, F. (2022). Smart Lipid-Polysaccharide Nanoparticles for Targeted Delivery of Doxorubicin to Breast Cancer Cells. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23042386"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/s41587-020-0707-9","article-title":"Mitochondrial Copper Depletion Suppresses Triple-Negative Breast Cancer in Mice","volume":"39","author":"Cui","year":"2021","journal-title":"Nat. Biotechnol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"7311","DOI":"10.1038\/s41467-021-27559-z","article-title":"Copper Depletion Modulates Mitochondrial Oxidative Phosphorylation to Impair Triple Negative Breast Cancer Metastasis","volume":"12","author":"Ramchandani","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"104340","DOI":"10.1016\/j.isci.2022.104340","article-title":"Gold(III)-P-Chirogenic Complex Induces Mitochondrial Dysfunction in Triple-Negative Breast Cancer","volume":"25","author":"Olelewe","year":"2022","journal-title":"iScience"},{"key":"ref_106","doi-asserted-by":"crossref","unstructured":"Cruz-Gregorio, A., Aranda-Rivera, A.K., Aparicio-Trejo, O.E., Medina-Campos, O.N., Sciutto, E., Fragoso, G., and Pedraza-Chaverri, J. (2022). GK-1 Induces Oxidative Stress, Mitochondrial Dysfunction, Decreased Membrane Potential, and Impaired Autophagy Flux in a Mouse Model of Breast Cancer. Antioxidants, 12.","DOI":"10.3390\/antiox12010056"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1056\/NEJMoa0808710","article-title":"IDH1 and IDH2 Mutations in Gliomas","volume":"360","author":"Yan","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"ref_108","doi-asserted-by":"crossref","unstructured":"(2012). The Cancer Genome Atlas Network. Comprehensive Molecular Portraits of Human Breast Tumours. Nature, 490, 61\u201370.","DOI":"10.1038\/nature11412"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/nature08617","article-title":"Cancer-Associated IDH1 Mutations Produce 2-Hydroxyglutarate","volume":"462","author":"Dang","year":"2009","journal-title":"Nature"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/nature10602","article-title":"Reductive Glutamine Metabolism by IDH1 Mediates Lipogenesis under Hypoxia","volume":"481","author":"Metallo","year":"2011","journal-title":"Nature"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/nature11066","article-title":"AMPK Regulates NADPH Homeostasis to Promote Tumour Cell Survival during Energy Stress","volume":"485","author":"Jeon","year":"2012","journal-title":"Nature"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"100265","DOI":"10.1016\/j.phyplu.2022.100265","article-title":"In Vitro Anticancer Efficacy of a Polyphenolic Combination of Quercetin, Curcumin, and Berberine in Triple Negative Breast Cancer (TNBC) Cells","volume":"2","author":"Kashyap","year":"2022","journal-title":"Phytomed. Plus"},{"key":"ref_113","first-page":"389","article-title":"The Effect of Metformin on Triple-Negative Breast Cancer Cells and Nude Mice","volume":"29","author":"Song","year":"2023","journal-title":"Altern. Ther. Health Med."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1038\/bjc.2012.56","article-title":"Phenformin as Prophylaxis and Therapy in Breast Cancer Xenografts","volume":"106","author":"Appleyard","year":"2012","journal-title":"Br. J. Cancer"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1089\/ars.2016.6677","article-title":"Selective Disruption of Respiratory Supercomplexes as a New Strategy to Suppress Her2high Breast Cancer","volume":"26","author":"Rohlenova","year":"2017","journal-title":"Antioxid. Redox Signal."},{"key":"ref_116","doi-asserted-by":"crossref","unstructured":"Ruiz, L.M., Libedinsky, A., and Elorza, A.A. (2021). Role of Copper on Mitochondrial Function and Metabolism. Front. Mol. Biosci., 8.","DOI":"10.3389\/fmolb.2021.711227"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"118867","DOI":"10.1016\/j.bbamcr.2020.118867","article-title":"Getting out What You Put in: Copper in Mitochondria and Its Impacts on Human Disease","volume":"1868","author":"Cobine","year":"2021","journal-title":"Biochim. Biophys. Acta (BBA)-Mol. Cell Res."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/iub.1722","article-title":"Copper Efflux Transporters ATP7A and ATP7B: Novel Biomarkers for Platinum Drug Resistance and Targets for Therapy","volume":"70","author":"Li","year":"2018","journal-title":"IUBMB Life"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.7150\/jca.19029","article-title":"A Role for The ATP7A Copper Transporter in Tumorigenesis and Cisplatin Resistance","volume":"8","author":"Zhu","year":"2017","journal-title":"J. Cancer"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1126\/science.abf0529","article-title":"Copper Induces Cell Death by Targeting Lipoylated TCA Cycle Proteins","volume":"375","author":"Tsvetkov","year":"2022","journal-title":"Science"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1126\/science.abo3959","article-title":"Copper-Induced Cell Death","volume":"375","author":"Kahlson","year":"2022","journal-title":"Science"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/s41556-023-01091-2","article-title":"Actin Cytoskeleton Vulnerability to Disulfide Stress Mediates Disulfidptosis","volume":"25","author":"Liu","year":"2023","journal-title":"Nat. Cell Biol."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1126\/science.aaw9872","article-title":"Cysteine Depletion Induces Pancreatic Tumor Ferroptosis in Mice","volume":"368","author":"Badgley","year":"2020","journal-title":"Science"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/s41420-025-02495-9","article-title":"Disulfidptosis in Tumor Progression","volume":"11","author":"Wan","year":"2025","journal-title":"Cell Death Discov."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1093\/procel\/pwae003","article-title":"Metabolic Cell Death in Cancer: Ferroptosis, Cuproptosis, Disulfidptosis, and Beyond","volume":"15","author":"Mao","year":"2024","journal-title":"Protein Cell"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"5107","DOI":"10.1038\/s41598-021-84492-3","article-title":"Lysyl Oxidase Engineered Lipid Nanovesicles for the Treatment of Triple Negative Breast Cancer","volume":"11","author":"Liverani","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.canlet.2007.08.003","article-title":"Up-Regulation of LOX-1 Expression by TNF-Alpha Promotes Trans-Endothelial Migration of MDA-MB-231 Breast Cancer Cells","volume":"258","author":"Liang","year":"2007","journal-title":"Cancer Lett."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1177\/153537020222600712","article-title":"Copper Control as an Antiangiogenic Anticancer Therapy: Lessons from Treating Wilson\u2019s Disease","volume":"226","author":"Brewer","year":"2001","journal-title":"Exp. Biol. Med."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/nature13180","article-title":"Copper Is Required for Oncogenic BRAF Signalling and Tumorigenesis","volume":"509","author":"Brady","year":"2014","journal-title":"Nature"},{"key":"ref_130","doi-asserted-by":"crossref","unstructured":"Prieto-Bermejo, R., and Hern\u00e1ndez-Hern\u00e1ndez, A. (2017). The Importance of NADPH Oxidases and Redox Signaling in Angiogenesis. Antioxidants, 6.","DOI":"10.3390\/antiox6020032"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/ardp.200600151","article-title":"Non Platinum Metal Complexes as Anti-Cancer Drugs","volume":"340","author":"Ott","year":"2007","journal-title":"Arch. Pharm."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.bcp.2009.07.023","article-title":"Cancer Cell Death Induced by Phosphine Gold(I) Compounds Targeting Thioredoxin Reductase","volume":"79","author":"Gandin","year":"2010","journal-title":"Biochem. Pharmacol."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.drup.2004.01.004","article-title":"ROS Stress in Cancer Cells and Therapeutic Implications","volume":"7","author":"Pelicano","year":"2004","journal-title":"Drug Resist. Updat."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/nrd2803","article-title":"Targeting Cancer Cells by ROS-Mediated Mechanisms: A Radical Therapeutic Approach?","volume":"8","author":"Trachootham","year":"2009","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"126814","DOI":"10.1016\/j.vaccine.2025.126814","article-title":"Antitumoral Effectiveness and Safety of Intravenous versus Subcutaneous Administration of Immunomodulatory Peptide GK-1 in a Murine Breast Cancer Model","volume":"50","author":"Moctezuma","year":"2025","journal-title":"Vaccine"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"eaaw5473","DOI":"10.1126\/science.aaw5473","article-title":"Metabolic Reprogramming and Cancer Progression","volume":"368","author":"Faubert","year":"2020","journal-title":"Science"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1126\/science.1160809","article-title":"Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation","volume":"324","author":"Cantley","year":"2009","journal-title":"Science"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1158\/2159-8290.CD-12-0345","article-title":"Cancer Cell Metabolism: One Hallmark, Many Faces","volume":"2","author":"Cantor","year":"2012","journal-title":"Cancer Discov."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.gendis.2023.02.052","article-title":"Cancer Organoids: A Platform in Basic and Translational Research","volume":"11","author":"Ma","year":"2023","journal-title":"Genes. Dis."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"4399","DOI":"10.1158\/0008-5472.CAN-21-0770","article-title":"Patient-Derived Xenografts to Study Cancer Metabolism: When Does X Mark the Spot?","volume":"81","author":"Nabel","year":"2021","journal-title":"Cancer Res."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"1534735419895591","DOI":"10.1177\/1534735419895591","article-title":"A Retrospective Study of Gemcitabine and Carboplatin With or Without Intravenous Vitamin C on Patients With Advanced Triple-Negative Breast Cancer","volume":"19","author":"Ou","year":"2020","journal-title":"Integr. Cancer Ther."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"13604","DOI":"10.1073\/pnas.0506390102","article-title":"Pharmacologic Ascorbic Acid Concentrations Selectively Kill Cancer Cells: Action as a pro-Drug to Deliver Hydrogen Peroxide to Tissues","volume":"102","author":"Chen","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.ccell.2017.02.018","article-title":"O2\u22c5- and H2O2-Mediated Disruption of Fe Metabolism Causes the Differential Susceptibility of NSCLC and GBM Cancer Cells to Pharmacological Ascorbate","volume":"31","author":"Schoenfeld","year":"2017","journal-title":"Cancer Cell"},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1126\/science.aaa5004","article-title":"Vitamin C Selectively Kills KRAS and BRAF Mutant Colorectal Cancer Cells by Targeting GAPDH","volume":"350","author":"Yun","year":"2015","journal-title":"Science"},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"222ra18","DOI":"10.1126\/scitranslmed.3007154","article-title":"High-Dose Parenteral Ascorbate Enhanced Chemosensitivity of Ovarian Cancer and Reduced Toxicity of Chemotherapy","volume":"6","author":"Ma","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1038\/s41416-018-0278-4","article-title":"Phase 1 Study of ARQ 761, a \u03b2-Lapachone Analogue That Promotes NQO1-Mediated Programmed Cancer Cell Necrosis","volume":"119","author":"Gerber","year":"2018","journal-title":"Br. J. Cancer"},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1158\/1078-0432.CCR-16-1326","article-title":"Influencing the Tumor Microenvironment: A Phase II Study of Copper Depletion Using Tetrathiomolybdate in Patients with Breast Cancer at High Risk for Recurrence and in Preclinical Models of Lung Metastases","volume":"23","author":"Chan","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"4264","DOI":"10.1158\/0008-5472.CAN-24-0800","article-title":"Simultaneous Targeting of NQO1 and SOD1 Eradicates Breast Cancer Stem Cells via Mitochondrial Futile Redox Cycling","volume":"84","author":"Luo","year":"2024","journal-title":"Cancer Res."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/jso.24624","article-title":"Using a Novel NQO1 Bioactivatable Drug, Beta-Lapachone (ARQ761), to Enhance Chemotherapeutic Effects by Metabolic Modulation in Pancreatic Cancer","volume":"116","author":"Beg","year":"2017","journal-title":"J. Surg. Oncol."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"5120","DOI":"10.1038\/s41467-020-18794-x","article-title":"Concepts of Extracellular Matrix Remodelling in Tumour Progression and Metastasis","volume":"11","author":"Winkler","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1158\/0008-5472.CAN-22-2034","article-title":"Collagens in Cancer: Structural Regulators and Guardians of Cancer Progression","volume":"83","year":"2023","journal-title":"Cancer Res."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1038\/ncb3039","article-title":"PGC-1\u03b1 Mediates Mitochondrial Biogenesis and Oxidative Phosphorylation to Promote Metastasis","volume":"16","author":"LeBleu","year":"2014","journal-title":"Nat. Cell Biol."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1038\/s41591-018-0052-4","article-title":"An Inhibitor of Oxidative Phosphorylation Exploits Cancer Vulnerability","volume":"24","author":"Molina","year":"2018","journal-title":"Nat. Med."},{"key":"ref_154","doi-asserted-by":"crossref","unstructured":"Kohli, M., and Poulogiannis, G. (2025). Harnessing the Power of Metabolomics for Precision Oncology: Current Advances and Future Directions. Cells, 14.","DOI":"10.3390\/cells14060402"},{"key":"ref_155","first-page":"903","article-title":"Organoid Models in Oncology: Advancing Precision Cancer Therapy and Vaccine Development","volume":"22","author":"Xiao","year":"2025","journal-title":"Cancer Biol. Med."}],"container-title":["Metabolites"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2218-1989\/16\/1\/60\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T09:36:29Z","timestamp":1769506589000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2218-1989\/16\/1\/60"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,9]]},"references-count":155,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,1]]}},"alternative-id":["metabo16010060"],"URL":"https:\/\/doi.org\/10.3390\/metabo16010060","relation":{},"ISSN":["2218-1989"],"issn-type":[{"value":"2218-1989","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,9]]}}}